Retina Institute of California
Ophthalmology
Dr. Tom S. Chang, MD
|
|
Give Review
Chang works in the field of Ophthalmology. He received awards:"CMS Meaningful Use Stage 1 Certification" and "Fellow (FAAO)". Dr. Tom S. Chang is a published MD as well. He has 23 publications published. The latest was: Driving ability reported by neovascular age-related macular degeneration patients after treatment with ranibizumab. Chang accepts Medicare payments and is listed with Medicare.gov.
Publications
- Driving ability reported by neovascular age-related Macular degeneration patients after treatment with ranibizumab.
- Stem cell therapy for retinal Disease.
- Short-term effectiveness of intravitreal bevacizumab versus ranibizumab injections for patients with neovascular age-related Macular degeneration.
- Perfused, but not leaking.
- Sutureless 25-gauge vitrectomy: risky or rewarding?
- Idiopathic retinitis, vasculitis, aneurysms, and neuroretinitis (IRVAN): new observations and a proposed staging system.
- Outcomes of 140 consecutive cases of 25-gauge transconjunctival surgery for posterior segment Disease.
- Anterior segment complications associated with scleral buckling.
- The white dot syndromes.
- Characteristics of visual loss by scanning laser ophthalmoscope microperimetry in eyes with subfoveal choroidal neovascularization secondary to age-related Macular deg...
- Inverted pneumatic retinopexy: a method of treating Retinal detachments associated with inferior Retinal breaks.
- Limited Macular translocation for the management of subfoveal choroidal neovascularization after photodynamic therapy.
- Validity of the SF-12 quality of life instrument in patients with retinal Diseases.
- A new 25-gauge instrument system for transconjunctival sutureless vitrectomy surgery.
- Initial experience using the transconjunctival sutureless vitrectomy system for vitreoRetinal surgery.
- Patient selection for Macular translocation surgery using the scanning laser ophthalmoscope.
- Assessment of vision-related function in patients with age-related Macular degeneration.
- Posterior Retinal vasculitis associated with multiple sclerosis.
- Improved vision-related function after ranibizumab treatment of neovascular age-related Macular degeneration: results of a randomized clinical trial.
- Induction of proliferative vitreoRetinopathy by a unique line of human retinal pigment epithelial cells.
- Improved vision-related function after ranibizumab vs photodynamic therapy: a randomized clinical trial.
- Vision-related function after ranibizumab treatment by better- or worse-seeing eye: clinical trial results from MARINA and ANCHOR.
Schools
University Of Toronto Faculty Of Medicine
Toronto General Hospital
University Western Ont
Bascom Palmer Eye Institute
Emory University
Johns Hopkins University
Procedures Preformed
- Destruction of Lesion of Retina and Choroid
- Eye Surgery
- Vitrectomy (incl. Macular Hole Repair)
Conditions Treated
- Age-Related Macular Degeneration
- Benign Neoplasm of Choroid
- Benign Neoplasm of Eye
- Cataract
- View All
Doctors Specialties
- Ophthalmology
Accepted Insurances
- Aetna HMO
- Basic HMO
- Choice Plus POS II
- Vitalidad Plus California Con Aetna
- Whole HealthPrimeCare California HMO
- Power Select HMO
- Blue Card PPO
- CaliforniaCare HMO
- Advantage Preferred DirectAccess Plus PPO
- Blue Cross Blue Shield of California PPO
- Pathway X Direct Access PPO
- Pathway X Guided Access HMO
- Pathway X Tiered Direct Access
- Priority Select HMO
- Select Plus HMO
- Access Plus Savenet
- Basic Exclusive PPO for Small Business
- Basic PPO
- Enhanced Exclusive for Small Business HMO
- Local Access Plus HMO
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- Open Access Plus
- Commercial Insurance Company
- Coventry Health Care
- First Health (Coventry Health Care) PPO
- Blue & Gold HMO
- Community Care Network HMO
- Covered California - Bronze PPO
- Employer Group HMO
- Health Net PPO
- Individual and Family PPO
- Medicare Advantage PFFS
- SmartCare HMO
- WholeCare Network HMO
- Humana
- Medicare MCR
- Molina Healthcare
- Kaiser PHCS Network PPO
- MultiPlan PPO
- PHCS Network PPO
- Heritage Signature
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- PacifiCare HMO
Awards
- CMS Meaningful Use Stage 1 Certification
- Fellow (FAAO)
Education
-
Emory University -
University of Toronto Faculty of Medicine
Hospital
-
Huntington Memorial Hospital
Drug Facts
| NPI NUMBER | 1609848969 | |
| NPPES Provider LastName | CHANG | |
| NPPES Provider FirstName | TOM | |
| NPPES Provider ZIPCode | 911053154 | |
| NPPES Provider State | CA | |
| Specialty Description | Ophthalmology | |
| Total Claim Count | 304.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1609848969 |
| Last Name Of The Provider | CHANG |
| First Name Of The Provider | TOM |
| View All |
Similar Doctors
|
Dr. David V. Leaming, MD
 This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
Dr. Ragui W. Sedeek, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Steven G. Lin, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Forrest P. Murphy, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Erik J. Williams, MD |
|
Dr. Michael A. Samuel, MD |
|
|
Dr. Shaden Sarafzadeh, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Keith A. Davis, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Salvador P. Pena-Quezada, MD |
|
|
Dr. William C. Murphy Jr., MD |